Table 4.
Prior to/during active surveillance, if the patient is a candidate for later active therapy | Where a patient is unsure whether to pursue definitive treatment |
Prior to ablation | Patients with chronic kidney disease |
Synchronous tumours to assess for genetic or syndromic aetiologies | Suspected metastases (particularly lymphoma) or an inflammatory mass where a diagnosis has not otherwise been achieved |
Young patients with small lesions—may be benign | A central infiltrating lesion where a transitional cell carcinoma is possible on imaging and only if urine cytological and endoscopic assessment have been unsuccessful |
SRM, small renal mass.